July. 11, 2018 - "In Q2 18 Orexo delivered one of the best quarters ever"
OCTOBER 1, 2018 To further strengthen the competitiveness and the long term profitability, Orexo has decided to internalize the remaining part of the contracted field force in the US. The decision has no material impact on the overall cost level or the guidance for 2018.
Orexo´s pipeline contains projects in different development phases, with a primary therapeutic focus around addiction in all phases, from prevention to treatment. One objective is to increase the pipeline with clinical stage projects. Read more about the development projects below.
American Society of Addiction Medicine: The treatment gap is huge for them with a substance use disorder. Just 10 p… https://t.co/OgnUFJ2Wwq
Mental illness is increasing worldwide and has a high correlation to use of opioid drugs. Today our thoughts go the… https://t.co/7iaDvuvaDW